Capricor Therapeutics (CAPR) Notes Payables (2010 - 2023)
Capricor Therapeutics (CAPR) posted quarterly Notes Payables of $282691.0 for Q1 2021, up 14.59% quarter-over-quarter from $246689.0 in Q4 2020.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Notes Payables (2010 - 2023) Analysis & Trends
Capricor Therapeutics' Notes Payables history runs 3 years deep, the most recent figure standing at $282691.0 for Q1 2021.
- In Q1 2021, Notes Payables changed N/A year-over-year to $282691.0; the TTM figure through Mar 2021 stood at $282691.0 (changed N/A YoY), while the FY2020 annual figure was $246689.0, changed N/A from the prior year.
- Notes Payables for Q1 2021 stood at $282691.0, up from $246689.0 in the prior quarter.
- The five-year high for Notes Payables was $282691.0 in Q1 2021, with the low at $139927.0 in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 543.30 Mn | 543.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 18,628.00 |
| Mar 31, 2023 | 18,716.00 |
| Dec 31, 2022 | 89,234.00 |
| Sep 30, 2022 | 84,156.00 |
| Jun 30, 2022 | 94,135.00 |
| Mar 31, 2022 | 574,848.00 |
| Dec 31, 2021 | 599,388.00 |
| Mar 31, 2021 | 282,691.00 |
| Dec 31, 2020 | 246,689.00 |
| Sep 30, 2020 | 193,241.00 |
| Jun 30, 2020 | 139,927.00 |
| Dec 31, 2013 | 41,855.00 |
| Sep 30, 2013 | 326,796.00 |
| Jun 30, 2013 | 258,514.00 |
| Mar 31, 2013 | 190,974.00 |
| Dec 31, 2012 | 16,139.00 |
| Sep 30, 2012 | 8,066.00 |
| Jun 30, 2012 | 36,448.00 |
| Mar 31, 2012 | 98,291.00 |
| Dec 31, 2011 | 38,892.00 |